Kyle Rudser, PhD, has been named director of CTSI’s Biostatistical Design and Analysis Center (BDAC).
In this role, he will oversee BDAC’s efforts to provide scientifically rigorous design and analysis of clinical research as well as dedicated support to the University of Minnesota’s research community. He will also provide leadership for the Biostatistics, Epidemiology, and Research Design (BERD) component of CTSI’s Clinical and Translational Science Award (CTSA).
Dr. Rudser has been a BDAC faculty biostatistician since 2008 and is also a Professor in the School of Public Health’s Division of Biostatistics. He has served on review committees for CTSI grant programs, mentors CTSI Scholars, and was honored as CTSI’s Biostatistical Mentor of the Year in 2016.
His statistical research interests include the design, monitoring, and analysis of clinical trials, survival analysis, longitudinal analysis, and nonparametric approaches. In addition to conducting research, Dr. Rudser teaches and serves as an academic adviser and committee member for students in the School of Public Health’s Biostatistics MS and PhD programs.
Dr. Rudser has MS and PhD degrees in Biostatistics from the University of Washington.
Dr. Rudser succeeds Haitao Chu, PhD, MD, who is departing the University of Minnesota for Pfizer.